Silence Therapeutics (SLN) Prices 5.71M Share Offering at $21/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
February 5, 2024 8:00 AM ESTLONDON--(BUSINESS WIRE)-- Silence Therapeutics plc (Nasdaq: SLN) (Silence or the Company), an experienced and innovative biotechnology company committed to transforming peoples lives by silencing diseases through precision engineered medicines, today announced an oversubscribed private placement of 5,714,286 of the Companys American Depositary Shares (ADSs)1 at a purchase price of US $21.00 per ADS, representing a premium of approximately 11% to Silences 30-day volume-weighted average price, with both new and existing institutional and accredited investors (the Private Placement). Silence anticipates that the aggregate gross proceeds of the Private Placement will be approximately US $120.0 million (approximately £94.6... More
